Sektor Outlook Therapeutics, Inc.

Aktien

A4046T

US69012T3059

OTLK

Biotechnologie

Realtime-Estimate 20:47:32 19.11.2026 Perf. 5 T Veränd. 1. Jan.
0.4010 USD -1.69% Intraday Chart für Outlook Therapeutics, Inc. -8.41% -74.49%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
-1.69%-8.41%-18.24%-41.59%-74.49%-79.43%-95.42%-98.69%-99.93% 99.3 Mio.
+0.19%-2.90%+0.06%-13.63%+59.30%+56.40%+69.15%+10.22% - 65.45 Mrd.
-0.14%-3.20%+17.59%-2.21%+19.73%+7.62%+90.41%+238.01%+6’323.65% 58.93 Mrd.
+0.06%+0.15%+8.77%+15.16%+24.02%+25.94%+86.73%-12.01%+267.09% 55.21 Mrd.
-0.41%-3.48%+8.46%+6.53%+32.15%+13.48%+113.69%+10.13%+1’174.14% 46.1 Mrd.
-2.37%-7.14%-5.31%+0.99%+11.69%+15.76%+22.64%-6.12%+214.62% 42.49 Mrd.
+3.61%+3.86%+10.82%+9.97%+24.72%+22.82%+46.39%+21.63%+195.61% 35.56 Mrd.
-0.10%-9.16%-12.05%-25.37%+101.14%+127.14%+637.25%+438.50% - 34.57 Mrd.
+0.03%-0.93%+37.57%+62.50%+72.52%+76.71%+57.52%+27.91%+180.88% 32.46 Mrd.
+20.91%+22.44%+51.71%+10.64%-16.94%-28.98%+487.16%+374.59%+888.78% 26.28 Mrd.
-1.79%-10.31%-9.05%-9.76%+39.44%+37.43%-7.22%-60.61% - 23.35 Mrd.
-2.12%-4.21%-8.69%-27.99%-14.43%-19.69%-17.58%-71.89% - 20.64 Mrd.
-1.55%-3.17%+2.64%+4.57%+13.25%+7.41%+130.48%+180.19%+1’669.76% 18.09 Mrd.
-5.01%-3.59%+11.97%-0.82% - - - - - 17.73 Mrd.
-3.39%-5.46%+5.34%+21.40%+50.65%+56.69%+215.48%+266.22%+284.57% 16.66 Mrd.
-1.23%-3.41%+9.73%+13.52%+65.03%+103.66%+72.78%-13.34%+354.45% 15.97 Mrd.
+0.71%-2.61%+8.51%+21.23%+37.28%+49.23%+66.65%-22.28%+101.51% 15.93 Mrd.
-3.21%-9.74%-3.21%-13.93%+184.40%+194.75%+309.77%+844.81%+686.93% 15.64 Mrd.
-1.84%-4.49%+13.89%+11.02%+5.09%+20.58%-29.08%-33.09%+150.62% 14.62 Mrd.
-0.52%-8.10%-6.64%-22.21%+7.60%-2.90%+369.41% - - 12.92 Mrd.
Durchschnitt +0.06%-4.67%+6.20%+1.00%+33.80%+36.03%+138.22%+116.34%+885.19% 28 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +0.47%-3.26%+8.00%+3.11%+38.15%+38.27%+137.98%+107.54%+1’375.47%
  1. Börse
  2. Aktien
  3. A4046T Aktie
  4. Sektor Outlook Therapeutics, Inc.